TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 36 filers reported holding TRACON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,428 | -84.6% | 11,780 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $22,264 | +26.8% | 11,780 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $17,552 | -7.6% | 11,780 | 0.0% | 0.00% | +100.0% |
| Q3 2022 | $19,000 | -20.8% | 11,780 | 0.0% | 0.00% | -66.7% |
| Q2 2022 | $24,000 | -22.6% | 11,780 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $31,000 | -6.1% | 11,780 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $33,000 | -25.0% | 11,780 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $44,000 | -42.1% | 11,780 | 0.0% | 0.01% | -45.5% |
| Q2 2021 | $76,000 | -20.8% | 11,780 | 0.0% | 0.01% | -31.2% |
| Q1 2021 | $96,000 | -48.7% | 11,780 | -26.4% | 0.02% | -59.0% |
| Q4 2020 | $187,000 | +125.3% | 16,000 | 0.0% | 0.04% | +95.0% |
| Q3 2020 | $83,000 | – | 16,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 4,764,508 | $848,082 | 0.28% |
| Ikarian Capital, LLC | 2,765,530 | $492,265 | 0.06% |
| JOHNSON & JOHNSON | 84,003 | $14,953 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 258,844 | $46,074 | 0.00% |
| BlackRock Inc. | 267,821 | $47,673 | 0.00% |
| Bank of New York Mellon Corp | 10,259 | $1,826 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 15,835 | $2,819 | 0.00% |
| Truvestments Capital LLC | 318 | $57 | 0.00% |
| Tower Research Capital LLC (TRC) | 10,407 | $1,852 | 0.00% |
| Cutler Group LLC / CA | 1,200 | $0 | 0.00% |